NRG1 and myopia: At the end of the treatment period, the right-eye axial length in the NRG-1 antibody group was significantly lower than that in the myopia group (myopia group: 8.61 ± 0.09 mm; low-dose NRG-1 antibody group: 8.51 ± 0.07 mm, p = 0.01; medium-dose NRG-1 antibody group: 8.43 ± 0.10 mm, p = 0.001; high-dose NRG-1 antibody group: 8.36 ± 0.07 mm, p < 0.001) (Table 1).